LobbyingVial lobbying by quarter
Vial's latest lobbying report covers Q3 2025, at under $5,000. Its first report covers Q1 2025; the issues it reports most are Health Issues.
Vial
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $60K | 1 |
| Q2 2025 | $90K | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$150K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| BGR Government Affairs | $150K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MARVIN BENITO FIGUEROA | COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White House | Q3 2025 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/20for Q3 2025 | BGR Government Affairs | Under $5,000 |
| 25/07/21for Q2 2025 | BGR Government Affairs | $90K |
| 25/04/21for Q1 2025 | BGR Government Affairs | $60K |
| 25/02/18for Q1 2025 | BGR Government Affairs | Under $5,000 |